Literature DB >> 27138807

Undescended testes: an update.

Andrew J A Holland1, Natasha Nassar, Francisco J Schneuer.   

Abstract

PURPOSE OF REVIEW: This article summarizes the latest evidence on the risk factors, management and outcomes of undescended testes (UDTs). RECENT
FINDINGS: UDTs remain common, with increasing evidence that acquired UDT or the ascending testis syndrome should be considered part of the spectrum of this disease. Prompt diagnosis and early referral for surgical evaluation and treatment would seem most likely to result in an optimal functional and cosmetic outcome. Hormonal treatment, rather than orchidopexy, remains popular in some centers, despite a lack of good evidence to support its efficacy, although it may have an important adjunct role in optimizing fertility. Although often performed, ultrasound does not generally assist in the diagnosis and management of UDT, with enhanced education of primary care physicians more likely to facilitate early referral. The testis, rather than quiescent, appears biologically active in the male infant, with increasing evidence of an adverse impact on future spermatogenesis and fertility in men with a UDT.
SUMMARY: Male infants with a UDT should be diagnosed and referred early for surgical evaluation. It seems likely that the optimal timing for surgery should be before the boy's first birthday. There remains a need for high-quality, long-term outcomes data to guide optimal management.

Entities:  

Mesh:

Year:  2016        PMID: 27138807     DOI: 10.1097/MOP.0000000000000335

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  2 in total

1.  Analysis of trends in testicular atrophy index values with age in patients with unilateral palpable cryptorchidism.

Authors:  Pei-Qiang Li; Yan Huang; Fu-Yun Liu
Journal:  Asian J Androl       Date:  2022 Sep-Oct       Impact factor: 3.054

2.  Urogenital Abnormalities in Adenosine Deaminase Deficiency.

Authors:  Roberta Pajno; Lucia Pacillo; Salvatore Recupero; Maria P Cicalese; Francesca Ferrua; Federica Barzaghi; Silvia Ricci; Antonio Marzollo; Silvia Pecorelli; Chiara Azzari; Andrea Finocchi; Caterina Cancrini; Gigliola Di Matteo; Gianni Russo; Massimo Alfano; Arianna Lesma; Andrea Salonia; Stuart Adams; Claire Booth; Alessandro Aiuti
Journal:  J Clin Immunol       Date:  2020-04-19       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.